PURIFICATION OF RECOMBINANT HISTIDINE-TAGGED CATALYTIC DOMAIN OF MMP-13 IN ONE-STEP USING AFFINITY COLUMN AND RENATURATION OF IT WITH HISTIDINE-TAG

Collagenase-3 (MMP-13) is a member of the matrix metalloproteinases (MMPs), which are closely related to a range of pathologies. The one-step purification of histidine-tagged (His-tagged) recombinant catalytic domain of collagenase-3 (His-cdMMP-13) expressed in Escherichia coli by Ni (II) immobilized metal ion affinity chromatography (IMAC) was investigated. Four factors, including the concentration of urea and NaCl in the binding buffer, flow rate, and loaded quantity, influencing the purity and recovery yield of the target protein were investigated in details. Under the optimal condition, binding buffer with 15 mM imidazole, a flow rate of 1.0 mL/min and 1.2 mL (22.7 mg) sample loaded, His-cdMMP-13 with purity of 98% and recovery yield of 57% was obtained. Further study showed that the adding of NaCl into binding buffer obviously improved the recovery yield to 71%, but decreased the purity to 91%. Finally, the activity of His-cdMMP-13 with His-tag could be renatured after refolding by gel chromatography.

[1]  M. Washburn,et al.  Affinity purification of protein complexes for analysis by multidimensional protein identification technology. , 2012, Protein expression and purification.

[2]  E. Novellino,et al.  N-O-isopropyl sulfonamido-based hydroxamates: kinetic characterisation of a series of MMP-12/MMP-13 dual target inhibitors. , 2012, Biochemical pharmacology.

[3]  Massimo Coletta,et al.  Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. , 2012, Molecular aspects of medicine.

[4]  Ke‐jian Wang,et al.  Optimized production of scygonadin in Pichia pastoris and analysis of its antimicrobial and antiviral activities. , 2012, Protein expression and purification.

[5]  D. Waugh.  An overview of enzymatic reagents for the removal of affinity tags , 2011, Protein Expression and Purification.

[6]  Y. M. Fobian,et al.  MMP-13 selective alpha-sulfone hydroxamates: identification of selective P1' amides. , 2011, Bioorganic & medicinal chemistry letters.

[7]  J. Qian,et al.  A NEW TRYPSIN AFFINITY MONOLITHIC CAPILLARY COLUMN PREPARED FROM GLYCERYLSILANE PRECURSOR THROUGH SOL-GEL METHOD , 2011 .

[8]  V. Pietra.  Identification of novel molecular scaffolds for the design of MMP-13 inhibitors through Virtual Screening Methods , 2010 .

[9]  T. Ling,et al.  Purification of histidine-tagged nucleocapsid protein of Nipah virus using immobilized metal affinity chromatography. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[10]  S. Im,et al.  Transcriptional regulation of MMP13 by Lef1 in chondrocytes. , 2007, Biochemical and biophysical research communications.

[11]  E. M. Martín del Valle,et al.  Immobilized Metal‐Ion Affinity Chromatography: Status and Trends , 2007 .

[12]  G. Petersen,et al.  Current strategies for the use of affinity tags and tag removal for the purification of recombinant proteins. , 2006, Protein expression and purification.

[13]  Song Tan,et al.  Comparison of affinity tags for protein purification. , 2005, Protein expression and purification.

[14]  V. Gupta,et al.  Optimization of immobilized metal ion affinity chromatography for single-step purification of recombinant ovine growth hormone expressed in Escherichia coli. , 2003, Journal of chromatography. A.

[15]  R. Grenman,et al.  Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells , 2002, Oncogene.

[16]  R. Ala-aho,et al.  Expression of collagenase‐3 (MMP‐13) enhances invasion of human fibrosarcoma HT‐1080 cells , 2002, International journal of cancer.

[17]  Yinmao Wei,et al.  PREPARATION AND CHROMATOGRAPHIC BEHAVIOR OF A BIFUNCTIONAL CONTINUOUS ROD FOR WEAK CATION EXCHANGE AND IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY , 2001 .

[18]  R. Beitle,et al.  Characterization of metal affinity of green fluorescent protein and its purification through salt promoted, immobilized metal affinity chromatography. , 2001, Journal of chromatography. A.

[19]  H. Tschesche,et al.  Matrix Metalloproteinases Collagenase-2, Macrophage Elastase, Collagenase-3, and Membrane Type 1-Matrix Metalloproteinase Impair Clotting by Degradation of Fibrinogen and Factor XII* , 2000, The Journal of Biological Chemistry.

[20]  X. Zhang,et al.  Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1. , 2000, Journal of molecular biology.

[21]  A. Patra,et al.  Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. , 2000, Protein expression and purification.

[22]  J. Koehn,et al.  The expression, refolding, and purification of the catalytic domain of human collagenase-3 (MMP-13). , 1998, Protein expression and purification.

[23]  K. P. Murphy,et al.  Urea effects on protein stability: Hydrogen bonding and the hydrophobic effect , 1998, Proteins.

[24]  E. Novellino,et al.  Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization. , 2012, European journal of medicinal chemistry.

[25]  F. Gomis-Rüth,et al.  Matrix metalloproteinases: fold and function of their catalytic domains. , 2010, Biochimica et biophysica acta.

[26]  C. López-Otín,et al.  Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. , 2010, Biochimica et biophysica acta.

[27]  J. Hahn.  Guide to protein purification. , 1990, Methods in enzymology.